Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids
Authors
Keywords
Asparagine, Glutamine, Branched chain amino acids, Metabolism, Glioma
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 128, Issue 1, Pages 57-66
Publisher
Springer Nature
Online
2016-02-27
DOI
10.1007/s11060-016-2073-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Identifying Glioblastoma Gene Networks Based on Hypergeometric Test Analysis
- (2015) Vasileios Stathias et al. PLoS One
- Targeting Metabolic Remodeling in Glioblastoma Multiforme
- (2015) Oncotarget
- Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors
- (2014) Eduard H. Panosyan et al. MOLECULAR CANCER RESEARCH
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
- (2014) Ji Zhang et al. MOLECULAR CELL
- Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma
- (2014) Sameer Agnihotri et al. Neurosurgical Focus
- The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
- (2014) Mira Patel et al. Cancers
- Metabolic Modulation of Epigenetics in Gliomas
- (2013) Sriram Venneti et al. BRAIN PATHOLOGY
- Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
- (2013) Qinglei Gao et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage
- (2013) Sergey Mareninov et al. JOURNAL OF NEURO-ONCOLOGY
- BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
- (2013) Martje Tönjes et al. NATURE MEDICINE
- Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas
- (2012) Arthur P. Chou et al. JNCI-Journal of the National Cancer Institute
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- DNA Damage Response and Growth Factor Signaling Pathways in Gliomagenesis and Therapeutic Resistance
- (2011) M. Squatrito et al. CANCER RESEARCH
- Metabolism and brain cancer
- (2011) Suely Kazue Nagahashi Marie et al. Clinics
- Molecular imaging of gliomas with PET: Opportunities and limitations
- (2011) C. la Fougere et al. NEURO-ONCOLOGY
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- (2011) Z. J. Reitman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
- (2008) Yohan Lee et al. BMC Medical Genomics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started